Fig. 4.

The measurements of TG production, VLDL size, and liver TG levels. Female Sms1/Sms2 double KO and control mice were treated with Poloxamer 407 (1 mg/ g of body weight, i.p.). Plasma TG was measured at 0, 1, 2 and 7 h. (A) plasma at 0, 1, 2 and 7 h after 407 treatment. (B) TG production quantification. (C) VLDL size was determined by NMR. M-TRLP, 37–49 nm; L-TRLP, 50–240 nm. (D) liver TG level quantification. Value is Means ± SD, n = 5, *P < 0.05.